These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23062569)

  • 1. Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.
    Wang CC; Reusch JE
    Am J Cardiol; 2012 Nov; 110(9 Suppl):58B-68B. PubMed ID: 23062569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline.
    Slinin Y; Ishani A; Rector T; Fitzgerald P; MacDonald R; Tacklind J; Rutks I; Wilt TJ
    Am J Kidney Dis; 2012 Nov; 60(5):747-69. PubMed ID: 22999165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.
    Huang ES; Meigs JB; Singer DE
    Am J Med; 2001 Dec; 111(8):633-42. PubMed ID: 11755507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment for hypertensive patients in special situations: diabetes and hypertension.
    Mogensen CE
    Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
    Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P
    Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WITHDRAWN: Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus.
    Fuller J; Stevens LK; Chaturvedi N; Holloway JF
    Cochrane Database Syst Rev; 2007 Jul; (4):CD002188. PubMed ID: 17636699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
    Zarich SW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S19-28. PubMed ID: 14668700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cardiovascular events in Japanese patients treated with fluvastatin from the long-term event monitoring (LEM) study.
    Morishita R; Itakura H; Nakaya N; Yoshida M; Odawara M; Ichihara A; Mizuno K
    Curr Vasc Pharmacol; 2012 Mar; 10(2):178-86. PubMed ID: 21824105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.
    Hanefeld M; Temelkova-Kurktschiev T
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):98-107. PubMed ID: 12189909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: 2002-2012 literature review.
    Moreno G; Mangione CM
    J Am Geriatr Soc; 2013 Nov; 61(11):2027-37. PubMed ID: 24219205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus.
    Fuller J; Stevens LK; Chaturvedi N; Holloway JF
    Cochrane Database Syst Rev; 2000; 1997(2):CD002188. PubMed ID: 10796872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and treatment by the primary care provider of common diabetes complications.
    Gilbert MP
    Med Clin North Am; 2015 Jan; 99(1):201-19. PubMed ID: 25456651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing cardiovascular risk in diabetes. Which factors to modify first?
    Spanheimer RG
    Postgrad Med; 2001 Apr; 109(4):26-30, 33-6. PubMed ID: 11317467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and cardiovascular disease prevention in older adults.
    Cigolle CT; Blaum CS; Halter JB
    Clin Geriatr Med; 2009 Nov; 25(4):607-41, vii-viii. PubMed ID: 19944264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.
    Heinl RE; Dhindsa DS; Mahlof EN; Schultz WM; Ricketts JC; Varghese T; Esmaeeli A; Allard-Ratick MP; Millard AJ; Kelli HM; Sandesara PB; Eapen DJ; Sperling L
    Can J Cardiol; 2016 Oct; 32(10 Suppl 2):S349-S357. PubMed ID: 27692115
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.